Listed

Ultragenyx Pharmaceutical Inc.

RARENasdaqCIK 1515673HealthcareFiscal year ends Dec 31

Share

Share this page

Story card, 1080 × 1920

Standardized line items from XBRL company facts, the last twelve quarters. Negative values are in parentheses. A figure marked d is derived from year-to-date figures.

Income statement

Revenue$214.0m, Q2 FY2026
Operating income−$75.0m, Q2 FY2026
Net income−$92.0m, Q2 FY2026
Line itemUnitQ3 FY20232023-09-30Q4 FY20232023-12-31Q1 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30Q4 FY20242024-12-31Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30Q4 FY20252025-12-31Q1 FY20262026-03-31Q2 FY20262026-06-30
Revenue$m98.1Revenue, Q3 FY2023, three months to 2023-09-30$98.1m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2024-11-06, accession 0000950170-24-121679.Report this figure127Revenue, Q4 FY2023, three months to 2023-12-31$127.1m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-02-18, accession 0001193125-26-057329. Derived: 12-month figure less the 9-month figure.Report this figure109Revenue, Q1 FY2024, three months to 2024-03-31$108.8m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2025-05-07, accession 0000950170-25-064726.Report this figure147Revenue, Q2 FY2024, three months to 2024-06-30$147.0m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2025-08-06, accession 0000950170-25-103290.Report this figure139Revenue, Q3 FY2024, three months to 2024-09-30$139.5m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2025-11-05, accession 0001193125-25-265126.Report this figure165Revenue, Q4 FY2024, three months to 2024-12-31$164.6m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-02-18, accession 0001193125-26-057329. Derived: 12-month figure less the 9-month figure.Report this figure139Revenue, Q1 FY2025, three months to 2025-03-31$139.0m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-05-06, accession 0001193125-26-206960.Report this figure167Revenue, Q2 FY2025, three months to 2025-06-30$167.0m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-08-05, accession 0001193125-26-333233.Report this figure160Revenue, Q3 FY2025, three months to 2025-09-30$159.9m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2025-11-05, accession 0001193125-25-265126.Report this figure207Revenue, Q4 FY2025, three months to 2025-12-31$207.3m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-02-18, accession 0001193125-26-057329. Derived: 12-month figure less the 9-month figure.Report this figure136Revenue, Q1 FY2026, three months to 2026-03-31$136.0m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-05-06, accession 0001193125-26-206960.Report this figure214Revenue, Q2 FY2026, three months to 2026-06-30$214.0m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-08-05, accession 0001193125-26-333233.Report this figure
Cost of revenue$mnot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reported
Research and development$m157Research and development, Q3 FY2023, three months to 2023-09-30$157.2m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2024-11-06, accession 0000950170-24-121679.Report this figure160Research and development, Q4 FY2023, three months to 2023-12-31$160.1m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-K filed 2026-02-18, accession 0001193125-26-057329. Derived: 12-month figure less the 9-month figure.Report this figure178Research and development, Q1 FY2024, three months to 2024-03-31$178.5m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-05-07, accession 0000950170-25-064726.Report this figure162Research and development, Q2 FY2024, three months to 2024-06-30$161.5m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-08-06, accession 0000950170-25-103290.Report this figure170Research and development, Q3 FY2024, three months to 2024-09-30$170.1m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-11-05, accession 0001193125-25-265126.Report this figure188Research and development, Q4 FY2024, three months to 2024-12-31$187.9m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-K filed 2026-02-18, accession 0001193125-26-057329. Derived: 12-month figure less the 9-month figure.Report this figure166Research and development, Q1 FY2025, three months to 2025-03-31$166.0m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-05-06, accession 0001193125-26-206960.Report this figure165Research and development, Q2 FY2025, three months to 2025-06-30$165.0m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-08-05, accession 0001193125-26-333233.Report this figure216Research and development, Q3 FY2025, three months to 2025-09-30$216.2m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-11-05, accession 0001193125-25-265126.Report this figure203Research and development, Q4 FY2025, three months to 2025-12-31$203.3m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-K filed 2026-02-18, accession 0001193125-26-057329. Derived: 12-month figure less the 9-month figure.Report this figure187Research and development, Q1 FY2026, three months to 2026-03-31$187.0m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-05-06, accession 0001193125-26-206960.Report this figure167Research and development, Q2 FY2026, three months to 2026-06-30$167.0m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-08-05, accession 0001193125-26-333233.Report this figure
Selling, general and administrative$m74.9Selling, general and administrative, Q3 FY2023, three months to 2023-09-30$74.9m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2024-11-06, accession 0000950170-24-121679.Report this figure77.0Selling, general and administrative, Q4 FY2023, three months to 2023-12-31$77.0m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-K filed 2026-02-18, accession 0001193125-26-057329. Derived: 12-month figure less the 9-month figure.Report this figure78.2Selling, general and administrative, Q1 FY2024, three months to 2024-03-31$78.2m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2025-05-07, accession 0000950170-25-064726.Report this figure80.6Selling, general and administrative, Q2 FY2024, three months to 2024-06-30$80.6m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2025-08-06, accession 0000950170-25-103290.Report this figure80.4Selling, general and administrative, Q3 FY2024, three months to 2024-09-30$80.4m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2025-11-05, accession 0001193125-25-265126.Report this figure81.9Selling, general and administrative, Q4 FY2024, three months to 2024-12-31$81.9m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-K filed 2026-02-18, accession 0001193125-26-057329. Derived: 12-month figure less the 9-month figure.Report this figure87.0Selling, general and administrative, Q1 FY2025, three months to 2025-03-31$87.0m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2026-05-06, accession 0001193125-26-206960.Report this figure87.0Selling, general and administrative, Q2 FY2025, three months to 2025-06-30$87.0m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2026-08-05, accession 0001193125-26-333233.Report this figure86.6Selling, general and administrative, Q3 FY2025, three months to 2025-09-30$86.6m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2025-11-05, accession 0001193125-25-265126.Report this figure87.9Selling, general and administrative, Q4 FY2025, three months to 2025-12-31$87.9m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-K filed 2026-02-18, accession 0001193125-26-057329. Derived: 12-month figure less the 9-month figure.Report this figure88.0Selling, general and administrative, Q1 FY2026, three months to 2026-03-31$88.0m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2026-05-06, accession 0001193125-26-206960.Report this figure88.0Selling, general and administrative, Q2 FY2026, three months to 2026-06-30$88.0m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2026-08-05, accession 0001193125-26-333233.Report this figure
Operating income$m(145)Operating income, Q3 FY2023, three months to 2023-09-30−$145.1m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2024-11-06, accession 0000950170-24-121679.Report this figure(122)Operating income, Q4 FY2023, three months to 2023-12-31−$121.8m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-02-18, accession 0001193125-26-057329. Derived: 12-month figure less the 9-month figure.Report this figure(165)Operating income, Q1 FY2024, three months to 2024-03-31−$165.3m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-05-07, accession 0000950170-25-064726.Report this figure(116)Operating income, Q2 FY2024, three months to 2024-06-30−$116.4m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-08-06, accession 0000950170-25-103290.Report this figure(132)Operating income, Q3 FY2024, three months to 2024-09-30−$132.0m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-11-05, accession 0001193125-25-265126.Report this figure(122)Operating income, Q4 FY2024, three months to 2024-12-31−$122.3m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-02-18, accession 0001193125-26-057329. Derived: 12-month figure less the 9-month figure.Report this figure(143)Operating income, Q1 FY2025, three months to 2025-03-31−$143.0m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-05-06, accession 0001193125-26-206960.Report this figure(108)Operating income, Q2 FY2025, three months to 2025-06-30−$108.0m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-08-05, accession 0001193125-26-333233.Report this figure(171)Operating income, Q3 FY2025, three months to 2025-09-30−$170.9m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-11-05, accession 0001193125-25-265126.Report this figure(113)Operating income, Q4 FY2025, three months to 2025-12-31−$113.3m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-02-18, accession 0001193125-26-057329. Derived: 12-month figure less the 9-month figure.Report this figure(169)Operating income, Q1 FY2026, three months to 2026-03-31−$169.0m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-05-06, accession 0001193125-26-206960.Report this figure(75.0)Operating income, Q2 FY2026, three months to 2026-06-30−$75.0m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-08-05, accession 0001193125-26-333233.Report this figure
Income tax$m0.7Income tax, Q3 FY2023, three months to 2023-09-30$650.0k. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2024-11-06, accession 0000950170-24-121679.Report this figure(3.9)Income tax, Q4 FY2023, three months to 2023-12-31−$3.9m. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-K filed 2026-02-18, accession 0001193125-26-057329. Derived: 12-month figure less the 9-month figure.Report this figure0.5Income tax, Q1 FY2024, three months to 2024-03-31$455.0k. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2025-05-07, accession 0000950170-25-064726.Report this figure0.9Income tax, Q2 FY2024, three months to 2024-06-30$858.0k. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2025-08-06, accession 0000950170-25-103290.Report this figure0.3Income tax, Q3 FY2024, three months to 2024-09-30$303.0k. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2025-11-05, accession 0001193125-25-265126.Report this figure0.4Income tax, Q4 FY2024, three months to 2024-12-31$384.0k. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-K filed 2026-02-18, accession 0001193125-26-057329. Derived: 12-month figure less the 9-month figure.Report this figure1.0Income tax, Q1 FY2025, three months to 2025-03-31$1.0m. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2026-05-06, accession 0001193125-26-206960.Report this figure1.0Income tax, Q2 FY2025, three months to 2025-06-30$1.0m. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2026-08-05, accession 0001193125-26-333233.Report this figure0.9Income tax, Q3 FY2025, three months to 2025-09-30$873.0k. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2025-11-05, accession 0001193125-25-265126.Report this figure0.9Income tax, Q4 FY2025, three months to 2025-12-31$870.0k. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-K filed 2026-02-18, accession 0001193125-26-057329. Derived: 12-month figure less the 9-month figure.Report this figure1.0Income tax, Q1 FY2026, three months to 2026-03-31$1.0m. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2026-05-06, accession 0001193125-26-206960.Report this figure1.0Income tax, Q2 FY2026, three months to 2026-06-30$1.0m. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2026-08-05, accession 0001193125-26-333233.Report this figure
Net income$m(160)Net income, Q3 FY2023, three months to 2023-09-30−$159.6m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2024-11-06, accession 0000950170-24-121679.Report this figure(124)Net income, Q4 FY2023, three months to 2023-12-31−$123.6m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-02-18, accession 0001193125-26-057329. Derived: 12-month figure less the 9-month figure.Report this figure(171)Net income, Q1 FY2024, three months to 2024-03-31−$170.7m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-05-07, accession 0000950170-25-064726.Report this figure(132)Net income, Q2 FY2024, three months to 2024-06-30−$131.6m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-08-06, accession 0000950170-25-103290.Report this figure(134)Net income, Q3 FY2024, three months to 2024-09-30−$133.5m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-11-05, accession 0001193125-25-265126.Report this figure(133)Net income, Q4 FY2024, three months to 2024-12-31−$133.2m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-02-18, accession 0001193125-26-057329. Derived: 12-month figure less the 9-month figure.Report this figure(151)Net income, Q1 FY2025, three months to 2025-03-31−$151.0m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-05-06, accession 0001193125-26-206960.Report this figure(115)Net income, Q2 FY2025, three months to 2025-06-30−$115.0m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-05, accession 0001193125-26-333233.Report this figure(180)Net income, Q3 FY2025, three months to 2025-09-30−$180.4m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-11-05, accession 0001193125-25-265126.Report this figure(129)Net income, Q4 FY2025, three months to 2025-12-31−$128.6m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-02-18, accession 0001193125-26-057329. Derived: 12-month figure less the 9-month figure.Report this figure(185)Net income, Q1 FY2026, three months to 2026-03-31−$185.0m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-05-06, accession 0001193125-26-206960.Report this figure(92.0)Net income, Q2 FY2026, three months to 2026-06-30−$92.0m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-05, accession 0001193125-26-333233.Report this figure
Diluted EPS$ per share(2.23)Diluted EPS, Q3 FY2023, three months to 2023-09-30−$2.23 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2024-11-06, accession 0000950170-24-121679.Report this figurenot reported(2.03)Diluted EPS, Q1 FY2024, three months to 2024-03-31−$2.03 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-05-07, accession 0000950170-25-064726.Report this figure(1.52)Diluted EPS, Q2 FY2024, three months to 2024-06-30−$1.52 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-08-06, accession 0000950170-25-103290.Report this figure(1.40)Diluted EPS, Q3 FY2024, three months to 2024-09-30−$1.40 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-11-05, accession 0001193125-25-265126.Report this figurenot reported(1.57)Diluted EPS, Q1 FY2025, three months to 2025-03-31−$1.57 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-05-06, accession 0001193125-26-206960.Report this figure(1.17)Diluted EPS, Q2 FY2025, three months to 2025-06-30−$1.17 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-08-05, accession 0001193125-26-333233.Report this figure(1.81)Diluted EPS, Q3 FY2025, three months to 2025-09-30−$1.81 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-11-05, accession 0001193125-25-265126.Report this figurenot reported(1.84)Diluted EPS, Q1 FY2026, three months to 2026-03-31−$1.84 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-05-06, accession 0001193125-26-206960.Report this figure(0.90)Diluted EPS, Q2 FY2026, three months to 2026-06-30−$0.90 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-08-05, accession 0001193125-26-333233.Report this figure
Basic EPS$ per share(2.23)Basic EPS, Q3 FY2023, three months to 2023-09-30−$2.23 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2024-11-06, accession 0000950170-24-121679.Report this figurenot reported(2.03)Basic EPS, Q1 FY2024, three months to 2024-03-31−$2.03 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-05-07, accession 0000950170-25-064726.Report this figure(1.52)Basic EPS, Q2 FY2024, three months to 2024-06-30−$1.52 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-08-06, accession 0000950170-25-103290.Report this figure(1.40)Basic EPS, Q3 FY2024, three months to 2024-09-30−$1.40 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-11-05, accession 0001193125-25-265126.Report this figurenot reported(1.57)Basic EPS, Q1 FY2025, three months to 2025-03-31−$1.57 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-05-06, accession 0001193125-26-206960.Report this figure(1.17)Basic EPS, Q2 FY2025, three months to 2025-06-30−$1.17 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-08-05, accession 0001193125-26-333233.Report this figure(1.81)Basic EPS, Q3 FY2025, three months to 2025-09-30−$1.81 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-11-05, accession 0001193125-25-265126.Report this figurenot reported(1.84)Basic EPS, Q1 FY2026, three months to 2026-03-31−$1.84 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-05-06, accession 0001193125-26-206960.Report this figure(0.90)Basic EPS, Q2 FY2026, three months to 2026-06-30−$0.90 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-08-05, accession 0001193125-26-333233.Report this figure

Balance sheet

Cash and equivalents$125.0m, Q2 FY2026
Shareholders' equity−$291.0m, Q2 FY2026
Line itemUnitQ3 FY20232023-09-30FY20232023-12-31Q1 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30FY20242024-12-31Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30FY20252025-12-31Q1 FY20262026-03-31Q2 FY20262026-06-30
Cash and equivalents$m72.6Cash and equivalents, Q3 FY2023, at 2023-09-30$72.6m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2024-11-06, accession 0000950170-24-121679.Report this figure214Cash and equivalents, FY2023, at 2023-12-31$214.0m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-K filed 2026-02-18, accession 0001193125-26-057329.Report this figure112Cash and equivalents, Q1 FY2024, at 2024-03-31$112.3m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2025-05-07, accession 0000950170-25-064726.Report this figure481Cash and equivalents, Q2 FY2024, at 2024-06-30$480.7m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2025-08-06, accession 0000950170-25-103290.Report this figure151Cash and equivalents, Q3 FY2024, at 2024-09-30$150.6m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2025-11-05, accession 0001193125-25-265126.Report this figure174Cash and equivalents, FY2024, at 2024-12-31$174.0m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-K filed 2026-02-18, accession 0001193125-26-057329.Report this figure127Cash and equivalents, Q1 FY2025, at 2025-03-31$127.0m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-05-06, accession 0001193125-26-206960.Report this figure176Cash and equivalents, Q2 FY2025, at 2025-06-30$176.0m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-08-05, accession 0001193125-26-333233.Report this figure203Cash and equivalents, Q3 FY2025, at 2025-09-30$202.5m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2025-11-05, accession 0001193125-25-265126.Report this figure421Cash and equivalents, FY2025, at 2025-12-31$421.0m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-08-05, accession 0001193125-26-333233.Report this figure175Cash and equivalents, Q1 FY2026, at 2026-03-31$175.0m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-05-06, accession 0001193125-26-206960.Report this figure125Cash and equivalents, Q2 FY2026, at 2026-06-30$125.0m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-08-05, accession 0001193125-26-333233.Report this figure
Current assets$m599Current assets, Q3 FY2023, at 2023-09-30$599.2m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2023-11-03, accession 0000950170-23-058427.Report this figure732Current assets, FY2023, at 2023-12-31$732.2m. XBRL concept us-gaap:AssetsCurrent. 10-K filed 2025-02-19, accession 0000950170-25-023312.Report this figure596Current assets, Q1 FY2024, at 2024-03-31$596.0m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2024-05-03, accession 0000950170-24-052346.Report this figure965Current assets, Q2 FY2024, at 2024-06-30$964.6m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2024-08-02, accession 0000950170-24-089488.Report this figure800Current assets, Q3 FY2024, at 2024-09-30$799.6m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2024-11-06, accession 0000950170-24-121679.Report this figure817Current assets, FY2024, at 2024-12-31$817.0m. XBRL concept us-gaap:AssetsCurrent. 10-K filed 2026-02-18, accession 0001193125-26-057329.Report this figure699Current assets, Q1 FY2025, at 2025-03-31$699.2m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2025-05-07, accession 0000950170-25-064726.Report this figure720Current assets, Q2 FY2025, at 2025-06-30$719.8m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2025-08-06, accession 0000950170-25-103290.Report this figure643Current assets, Q3 FY2025, at 2025-09-30$643.2m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2025-11-05, accession 0001193125-25-265126.Report this figure951Current assets, FY2025, at 2025-12-31$951.0m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2026-08-05, accession 0001193125-26-333233.Report this figure657Current assets, Q1 FY2026, at 2026-03-31$657.0m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2026-05-06, accession 0001193125-26-206960.Report this figure606Current assets, Q2 FY2026, at 2026-06-30$606.0m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2026-08-05, accession 0001193125-26-333233.Report this figure
Total assets$m1,238Total assets, Q3 FY2023, at 2023-09-30$1.24bn. XBRL concept us-gaap:Assets. 10-Q filed 2023-11-03, accession 0000950170-23-058427.Report this figure1,491Total assets, FY2023, at 2023-12-31$1.49bn. XBRL concept us-gaap:Assets. 10-K filed 2025-02-19, accession 0000950170-25-023312.Report this figure1,307Total assets, Q1 FY2024, at 2024-03-31$1.31bn. XBRL concept us-gaap:Assets. 10-Q filed 2024-05-03, accession 0000950170-24-052346.Report this figure1,618Total assets, Q2 FY2024, at 2024-06-30$1.62bn. XBRL concept us-gaap:Assets. 10-Q filed 2024-08-02, accession 0000950170-24-089488.Report this figure1,538Total assets, Q3 FY2024, at 2024-09-30$1.54bn. XBRL concept us-gaap:Assets. 10-Q filed 2024-11-06, accession 0000950170-24-121679.Report this figure1,503Total assets, FY2024, at 2024-12-31$1.50bn. XBRL concept us-gaap:Assets. 10-K filed 2026-02-18, accession 0001193125-26-057329.Report this figure1,312Total assets, Q1 FY2025, at 2025-03-31$1.31bn. XBRL concept us-gaap:Assets. 10-Q filed 2025-05-07, accession 0000950170-25-064726.Report this figure1,306Total assets, Q2 FY2025, at 2025-06-30$1.31bn. XBRL concept us-gaap:Assets. 10-Q filed 2025-08-06, accession 0000950170-25-103290.Report this figure1,190Total assets, Q3 FY2025, at 2025-09-30$1.19bn. XBRL concept us-gaap:Assets. 10-Q filed 2025-11-05, accession 0001193125-25-265126.Report this figure1,532Total assets, FY2025, at 2025-12-31$1.53bn. XBRL concept us-gaap:Assets. 10-Q filed 2026-08-05, accession 0001193125-26-333233.Report this figure1,296Total assets, Q1 FY2026, at 2026-03-31$1.30bn. XBRL concept us-gaap:Assets. 10-Q filed 2026-05-06, accession 0001193125-26-206960.Report this figure1,264Total assets, Q2 FY2026, at 2026-06-30$1.26bn. XBRL concept us-gaap:Assets. 10-Q filed 2026-08-05, accession 0001193125-26-333233.Report this figure
Current liabilities$m254Current liabilities, Q3 FY2023, at 2023-09-30$254.0m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2023-11-03, accession 0000950170-23-058427.Report this figure280Current liabilities, FY2023, at 2023-12-31$280.4m. XBRL concept us-gaap:LiabilitiesCurrent. 10-K filed 2025-02-19, accession 0000950170-25-023312.Report this figure246Current liabilities, Q1 FY2024, at 2024-03-31$245.6m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2024-05-03, accession 0000950170-24-052346.Report this figure273Current liabilities, Q2 FY2024, at 2024-06-30$272.9m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2024-08-02, accession 0000950170-24-089488.Report this figure285Current liabilities, Q3 FY2024, at 2024-09-30$285.0m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2024-11-06, accession 0000950170-24-121679.Report this figure344Current liabilities, FY2024, at 2024-12-31$344.0m. XBRL concept us-gaap:LiabilitiesCurrent. 10-K filed 2026-02-18, accession 0001193125-26-057329.Report this figure292Current liabilities, Q1 FY2025, at 2025-03-31$291.7m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2025-05-07, accession 0000950170-25-064726.Report this figure293Current liabilities, Q2 FY2025, at 2025-06-30$293.2m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2025-08-06, accession 0000950170-25-103290.Report this figure340Current liabilities, Q3 FY2025, at 2025-09-30$340.0m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2025-11-05, accession 0001193125-25-265126.Report this figure384Current liabilities, FY2025, at 2025-12-31$384.0m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2026-08-05, accession 0001193125-26-333233.Report this figure325Current liabilities, Q1 FY2026, at 2026-03-31$325.0m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2026-05-06, accession 0001193125-26-206960.Report this figure351Current liabilities, Q2 FY2026, at 2026-06-30$351.0m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2026-08-05, accession 0001193125-26-333233.Report this figure
Total liabilities$m1,206Total liabilities, Q3 FY2023, at 2023-09-30$1.21bn. XBRL concept us-gaap:Liabilities. 10-Q filed 2023-11-03, accession 0000950170-23-058427.Report this figure1,216Total liabilities, FY2023, at 2023-12-31$1.22bn. XBRL concept us-gaap:Liabilities. 10-K filed 2025-02-19, accession 0000950170-25-023312.Report this figure1,167Total liabilities, Q1 FY2024, at 2024-03-31$1.17bn. XBRL concept us-gaap:Liabilities. 10-Q filed 2024-05-03, accession 0000950170-24-052346.Report this figure1,186Total liabilities, Q2 FY2024, at 2024-06-30$1.19bn. XBRL concept us-gaap:Liabilities. 10-Q filed 2024-08-02, accession 0000950170-24-089488.Report this figure1,185Total liabilities, Q3 FY2024, at 2024-09-30$1.18bn. XBRL concept us-gaap:Liabilities. 10-Q filed 2024-11-06, accession 0000950170-24-121679.Report this figure1,241Total liabilities, FY2024, at 2024-12-31$1.24bn. XBRL concept us-gaap:Liabilities. 10-K filed 2026-02-18, accession 0001193125-26-057329.Report this figure1,161Total liabilities, Q1 FY2025, at 2025-03-31$1.16bn. XBRL concept us-gaap:Liabilities. 10-Q filed 2025-05-07, accession 0000950170-25-064726.Report this figure1,148Total liabilities, Q2 FY2025, at 2025-06-30$1.15bn. XBRL concept us-gaap:Liabilities. 10-Q filed 2025-08-06, accession 0000950170-25-103290.Report this figure1,174Total liabilities, Q3 FY2025, at 2025-09-30$1.17bn. XBRL concept us-gaap:Liabilities. 10-Q filed 2025-11-05, accession 0001193125-25-265126.Report this figure1,605Total liabilities, FY2025, at 2025-12-31$1.60bn. XBRL concept us-gaap:Liabilities. 10-Q filed 2026-08-05, accession 0001193125-26-333233.Report this figure1,525Total liabilities, Q1 FY2026, at 2026-03-31$1.52bn. XBRL concept us-gaap:Liabilities. 10-Q filed 2026-05-06, accession 0001193125-26-206960.Report this figure1,548Total liabilities, Q2 FY2026, at 2026-06-30$1.55bn. XBRL concept us-gaap:Liabilities. 10-Q filed 2026-08-05, accession 0001193125-26-333233.Report this figure
Shareholders' equity$m31.7Shareholders' equity, Q3 FY2023, at 2023-09-30$31.7m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2024-11-06, accession 0000950170-24-121679.Report this figure275Shareholders' equity, FY2023, at 2023-12-31$275.0m. XBRL concept us-gaap:StockholdersEquity. 10-K filed 2026-02-18, accession 0001193125-26-057329.Report this figure140Shareholders' equity, Q1 FY2024, at 2024-03-31$140.3m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-08-06, accession 0000950170-25-103290.Report this figure432Shareholders' equity, Q2 FY2024, at 2024-06-30$432.4m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-11-05, accession 0001193125-25-265126.Report this figure347Shareholders' equity, Q3 FY2024, at 2024-09-30$346.8m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-11-05, accession 0001193125-25-265126.Report this figure255Shareholders' equity, FY2024, at 2024-12-31$255.0m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-05, accession 0001193125-26-333233.Report this figure144Shareholders' equity, Q1 FY2025, at 2025-03-31$144.0m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-05, accession 0001193125-26-333233.Report this figure151Shareholders' equity, Q2 FY2025, at 2025-06-30$151.0m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-05, accession 0001193125-26-333233.Report this figure9.2Shareholders' equity, Q3 FY2025, at 2025-09-30$9.2m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-11-05, accession 0001193125-25-265126.Report this figure(80.0)Shareholders' equity, FY2025, at 2025-12-31−$80.0m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-05, accession 0001193125-26-333233.Report this figure(236)Shareholders' equity, Q1 FY2026, at 2026-03-31−$236.0m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-05, accession 0001193125-26-333233.Report this figure(291)Shareholders' equity, Q2 FY2026, at 2026-06-30−$291.0m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-05, accession 0001193125-26-333233.Report this figure

Cash flow

Operating cash flow−$97.0m, Q2 FY2026
Capital expenditure$1.0m, Q2 FY2026
Line itemUnitQ3 FY20232023-09-30Q4 FY20232023-12-31Q1 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30Q4 FY20242024-12-31Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30Q4 FY20252025-12-31Q1 FY20262026-03-31Q2 FY20262026-06-30
Operating cash flow$m(118)Operating cash flow, Q3 FY2023, three months to 2023-09-30−$117.9m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2024-11-06, accession 0000950170-24-121679. Derived: 9-month figure less the 6-month figure.Report this figure(84.1)Operating cash flow, Q4 FY2023, three months to 2023-12-31−$84.1m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-02-18, accession 0001193125-26-057329. Derived: 12-month figure less the 9-month figure.Report this figure(191)Operating cash flow, Q1 FY2024, three months to 2024-03-31−$190.7m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-05-07, accession 0000950170-25-064726.Report this figure(77.0)Operating cash flow, Q2 FY2024, three months to 2024-06-30−$77.0m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-08-06, accession 0000950170-25-103290. Derived: 6-month figure less the 3-month figure.Report this figure(67.0)Operating cash flow, Q3 FY2024, three months to 2024-09-30−$67.0m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-11-05, accession 0001193125-25-265126. Derived: 9-month figure less the 6-month figure.Report this figure(79.3)Operating cash flow, Q4 FY2024, three months to 2024-12-31−$79.3m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-02-18, accession 0001193125-26-057329. Derived: 12-month figure less the 9-month figure.Report this figure(166)Operating cash flow, Q1 FY2025, three months to 2025-03-31−$166.0m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-05-06, accession 0001193125-26-206960.Report this figure(109)Operating cash flow, Q2 FY2025, three months to 2025-06-30−$109.0m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-08-05, accession 0001193125-26-333233. Derived: 6-month figure less the 3-month figure.Report this figure(91.2)Operating cash flow, Q3 FY2025, three months to 2025-09-30−$91.2m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-11-05, accession 0001193125-25-265126. Derived: 9-month figure less the 6-month figure.Report this figure(99.8)Operating cash flow, Q4 FY2025, three months to 2025-12-31−$99.8m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-02-18, accession 0001193125-26-057329. Derived: 12-month figure less the 9-month figure.Report this figure(197)Operating cash flow, Q1 FY2026, three months to 2026-03-31−$197.0m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-05-06, accession 0001193125-26-206960.Report this figure(97.0)Operating cash flow, Q2 FY2026, three months to 2026-06-30−$97.0m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-08-05, accession 0001193125-26-333233. Derived: 6-month figure less the 3-month figure.Report this figure
Capital expenditure$m3.7Capital expenditure, Q3 FY2023, three months to 2023-09-30$3.7m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2024-11-06, accession 0000950170-24-121679. Derived: 9-month figure less the 6-month figure.Report this figure1.3Capital expenditure, Q4 FY2023, three months to 2023-12-31$1.3m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2026-02-18, accession 0001193125-26-057329. Derived: 12-month figure less the 9-month figure.Report this figure3.2Capital expenditure, Q1 FY2024, three months to 2024-03-31$3.2m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-05-07, accession 0000950170-25-064726.Report this figure2.0Capital expenditure, Q2 FY2024, three months to 2024-06-30$2.0m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-08-06, accession 0000950170-25-103290. Derived: 6-month figure less the 3-month figure.Report this figure1.6Capital expenditure, Q3 FY2024, three months to 2024-09-30$1.6m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-11-05, accession 0001193125-25-265126. Derived: 9-month figure less the 6-month figure.Report this figure0.2Capital expenditure, Q4 FY2024, three months to 2024-12-31$163.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2026-02-18, accession 0001193125-26-057329. Derived: 12-month figure less the 9-month figure.Report this figure1.0Capital expenditure, Q1 FY2025, three months to 2025-03-31$1.0m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-05-06, accession 0001193125-26-206960.Report this figure3.0Capital expenditure, Q2 FY2025, three months to 2025-06-30$3.0m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-08-05, accession 0001193125-26-333233. Derived: 6-month figure less the 3-month figure.Report this figure1.1Capital expenditure, Q3 FY2025, three months to 2025-09-30$1.1m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-11-05, accession 0001193125-25-265126. Derived: 9-month figure less the 6-month figure.Report this figure0.9Capital expenditure, Q4 FY2025, three months to 2025-12-31$938.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2026-02-18, accession 0001193125-26-057329. Derived: 12-month figure less the 9-month figure.Report this figure1.0Capital expenditure, Q1 FY2026, three months to 2026-03-31$1.0m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-05-06, accession 0001193125-26-206960.Report this figure1.0Capital expenditure, Q2 FY2026, three months to 2026-06-30$1.0m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-08-05, accession 0001193125-26-333233. Derived: 6-month figure less the 3-month figure.Report this figure
Dividends paid$mnot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reported

Shares

Diluted shares (weighted)101.90m, Q2 FY2026
Line itemUnitQ3 FY20222022-09-30Q1 FY20232023-03-31Q2 FY20232023-06-30Q3 FY20232023-09-30Q1 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30Q1 FY20262026-03-31Q2 FY20262026-06-30
Diluted shares (weighted)m shares70.1Diluted shares (weighted), Q3 FY2022, three months to 2022-09-3070,054,173 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2023-11-03, accession 0000950170-23-058427.Report this figure70.4Diluted shares (weighted), Q1 FY2023, three months to 2023-03-3170,368,478 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2024-05-03, accession 0000950170-24-052346.Report this figure70.9Diluted shares (weighted), Q2 FY2023, three months to 2023-06-3070,897,991 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2024-08-02, accession 0000950170-24-089488.Report this figure71.7Diluted shares (weighted), Q3 FY2023, three months to 2023-09-3071,664,493 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2024-11-06, accession 0000950170-24-121679.Report this figure84.3Diluted shares (weighted), Q1 FY2024, three months to 2024-03-3184,286,292 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-05-07, accession 0000950170-25-064726.Report this figure86.6Diluted shares (weighted), Q2 FY2024, three months to 2024-06-3086,580,516 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-08-06, accession 0000950170-25-103290.Report this figure95.5Diluted shares (weighted), Q3 FY2024, three months to 2024-09-3095,493,996 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-11-05, accession 0001193125-25-265126.Report this figure96.3Diluted shares (weighted), Q1 FY2025, three months to 2025-03-3196,300,000 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-05-06, accession 0001193125-26-206960.Report this figure98.5Diluted shares (weighted), Q2 FY2025, three months to 2025-06-3098,500,000 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-08-05, accession 0001193125-26-333233.Report this figure99.8Diluted shares (weighted), Q3 FY2025, three months to 2025-09-3099,771,297 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-11-05, accession 0001193125-25-265126.Report this figure101Diluted shares (weighted), Q1 FY2026, three months to 2026-03-31100,600,000 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-05-06, accession 0001193125-26-206960.Report this figure102Diluted shares (weighted), Q2 FY2026, three months to 2026-06-30101,900,000 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-08-05, accession 0001193125-26-333233.Report this figure

Shares outstanding: 98.59mShares outstanding, period not labelled, at 2026-07-3198,588,873 shares. XBRL concept dei:EntityCommonStockSharesOutstanding. 10-Q filed 2026-08-05, accession 0001193125-26-333233.Report this figure at Jul 31, 2026, from the cover of the 10-Q filed Aug 5, 2026.

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:41 ET. Listed shows no prices and gives no investment advice.